Sean M. McBride

7.2k total citations · 3 hit papers
214 papers, 4.2k citations indexed

About

Sean M. McBride is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Sean M. McBride has authored 214 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 95 papers in Otorhinolaryngology and 67 papers in Oncology. Recurrent topics in Sean M. McBride's work include Head and Neck Cancer Studies (92 papers), Prostate Cancer Diagnosis and Treatment (59 papers) and Prostate Cancer Treatment and Research (58 papers). Sean M. McBride is often cited by papers focused on Head and Neck Cancer Studies (92 papers), Prostate Cancer Diagnosis and Treatment (59 papers) and Prostate Cancer Treatment and Research (58 papers). Sean M. McBride collaborates with scholars based in United States, Canada and China. Sean M. McBride's co-authors include Nancy Y. Lee, Nadeem Riaz, Eric J. Sherman, Michael J. Zeléfsky, C. Jillian Tsai, Marisa Kollmeier, Zhigang Zhang, Xin Pei, Jonathan E. Leeman and Paul B. Romesser and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sean M. McBride

197 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

2020 264 citations Sean M. McBride, Eric J. Sherman et al. Journal of Clinical Oncology profile →
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

2022 226 citations Sean M. McBride et al. profile →
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

2022 124 citations Sean M. McBride et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sean M. McBride	2.4k	1.1k	1.1k	1.0k	892	214	4.2k
Jimmy J. Caudell	1.7k 0.7×	1.4k 1.3×	1.4k 1.4×	1.2k 1.2×	618 0.7×	157	4.0k
Zachary S. Zumsteg	1.9k 0.8×	982 0.9×	1.3k 1.2×	1.1k 1.0×	429 0.5×	116	3.8k
Hiram A. Gay	1.7k 0.7×	824 0.7×	909 0.9×	991 1.0×	1.4k 1.6×	189	4.0k
Andrew Bayley	2.1k 0.9×	1.0k 0.9×	1.9k 1.8×	1.7k 1.7×	1.1k 1.2×	158	4.3k
Jiade J. Lu	2.0k 0.8×	1.5k 1.3×	1.6k 1.5×	1.6k 1.6×	771 0.9×	186	4.5k
Megan E. Daly	1.8k 0.8×	1.2k 1.0×	1.2k 1.2×	1.1k 1.0×	921 1.0×	117	4.0k
Adam Raben	3.0k 1.3×	1.1k 1.0×	1.1k 1.1×	1.1k 1.1×	1.5k 1.7×	80	4.7k
Stefano Maria Magrini	1.4k 0.6×	748 0.7×	538 0.5×	555 0.5×	356 0.4×	163	2.7k
Allen M. Chen	1.3k 0.6×	1.3k 1.1×	2.2k 2.1×	1.9k 1.9×	741 0.8×	133	3.9k
Jean‐Jacques Mazeron	2.5k 1.1×	995 0.9×	547 0.5×	1.2k 1.2×	1.1k 1.3×	151	4.6k

Countries citing papers authored by Sean M. McBride

Since Specialization

Citations

This map shows the geographic impact of Sean M. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean M. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean M. McBride more than expected).

Fields of papers citing papers by Sean M. McBride

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean M. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean M. McBride. The network helps show where Sean M. McBride may publish in the future.

Co-authorship network of co-authors of Sean M. McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Sean M. McBride. A scholar is included among the top collaborators of Sean M. McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean M. McBride. Sean M. McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dee, Edward Christopher, Yao Yu, Daphna Y. Gelblum, et al.. (2025). Partial vs Whole Laryngeal Radiotherapy for Clinical Stage T1-2N0M0/Tis Laryngeal Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 151(11). 1071–1071.

Riaz, Nadeem, Sean M. McBride, Daphna Y. Gelblum, et al.. (2025). Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure. Head & Neck. 48(3). 774–781.

Dee, Edward Christopher, et al.. (2024). Nasopharynx Cancer in the United States: Racial and Ethnic Disparities in Stage at Presentation. The Laryngoscope. 135(3). 1113–1119. 3 indexed citations

McBride, Sean M., Helen Hughes, & Shannon M. MacDonald. (2024). Future of Telemedicine in Radiation Oncology. Seminars in Radiation Oncology. 34(4). 463–467. 3 indexed citations

Walmsley, Charlotte S., Philip Jonsson, Michael L. Cheng, et al.. (2024). Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy. npj Precision Oncology. 8(1). 34–34. 7 indexed citations

Han, James E., Kaveh Zakeri, Gabriel Raab, et al.. (2023). Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. Head & Neck. 45(9). 2207–2216. 7 indexed citations

Yilmaz, Emrullah, Nofisat Ismaila, Julie E. Bauman, et al.. (2022). Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. Journal of Clinical Oncology. 41(5). 1132–1146. 49 indexed citations

Dee, Edward Christopher, Neil K. Taunk, Fumiko Chino, et al.. (2022). Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality. JCO Oncology Practice. 19(2). e197–e212. 14 indexed citations

Zeléfsky, Michael J., Debra A. Goldman, Sean M. McBride, et al.. (2021). Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. Radiotherapy and Oncology. 159. 33–38. 20 indexed citations

10.

Kang, Jung Julie, Anna Lee, Sarin Kitpanit, et al.. (2021). The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers. Head & Neck. 43(12). 3796–3809. 1 indexed citations

11.

McBride, Sean M., Eric J. Sherman, C. Jillian Tsai, et al.. (2020). Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. Journal of Clinical Oncology. 39(1). 30–37. 264 indexed citations breakdown →

12.

Cohen, Marc A., David G. Pfister, Nancy Y. Lee, et al.. (2020). Case study of the integration of electronic patient‐reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities. Cancer. 127(3). 359–371. 12 indexed citations

13.

Zakian, Kristen L., Andreas G. Wibmer, Hebert Alberto Vargas, et al.. (2019). Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR Simulation. Practical Radiation Oncology. 9(6). e534–e540. 15 indexed citations

14.

Xiao, Roy, Qasim Husain, Jennifer R. Cracchiolo, et al.. (2019). Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach. Head & Neck. 41(10). 3551–3563. 15 indexed citations

15.

Yu, Yao, Marlena McGill, Christopher A. Barker, et al.. (2019). Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy‐free survival in those refusing surgery. Head & Neck. 41(8). 2741–2747. 8 indexed citations

16.

Husain, Qasim, Benjamin R. Roman, Jennifer R. Cracchiolo, et al.. (2018). Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. Journal of Surgical Oncology. 119(1). 130–142. 31 indexed citations

17.

Roman, Benjamin R., Shrujal S. Baxi, Jennifer R. Cracchiolo, et al.. (2017). Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database. Journal of Surgical Oncology. 116(3). 351–358. 6 indexed citations

18.

Cracchiolo, Jennifer R., Krupa R. Patel, Jocelyn Migliacci, et al.. (2017). Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma. Journal of Surgical Oncology. 117(4). 756–764. 31 indexed citations

19.

McBride, Sean M., Nadeem Riaz, Jonathan E. Leeman, et al.. (2016). Number of Lymph Nodes Examined Is Associated With Overall Survival in Clinically Node-Negative Oral Cavity Cancer Patients Receiving Definitive Surgery—A Population-Based Analysis Using the National Cancer Data Base. International Journal of Radiation Oncology*Biology*Physics. 96(2). E338–E339. 1 indexed citations

20.

Higginson, Daniel S., Eli D. Scher, Lindsey Mitrani, et al.. (2015). Use of Human Papillomavirus 16 (HPV16) Cell Free DNA for Assessment of Response to Chemoradiation in HPV-Associated Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S78–S79. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact